Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$116,320,390
-$41,661,115 QoQ
Shares Held
4,830,581
-14.1% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#92
of 2,820 holders
Holding Since
Mar 2023
14 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Empower Advisory Group, LLC holds $946,768,864 across 11 Drug Manufacturers - General names. PFE ranks #5 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
268,075 | $321,537,224 | |
| 2 | JNJ |
Johnson & Johnson
|
905,317 | $229,923,358 | |
| 3 | ABBV |
AbbVie Inc.
|
507,376 | $127,676,096 | |
| 4 | AMGN |
Amgen Inc
|
349,667 | $126,621,414 | |
| 5 | PFE |
Pfizer Inc
This page
|
4,830,581 | $116,320,390 | |
| 6 | MRK |
Merck & Co., Inc.
|
169,726 | $21,809,791 | |
| 7 | AZN |
Astrazeneca PLC
|
5,682 | $1,077,420 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,129 | $900,677 |
All Filings in PFE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,320,390 | 4,830,581 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $157,981,505 | 5,626,122 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $128,076,113 | 5,143,619 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $128,300,488 | 5,035,341 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $117,521,216 | 4,848,235 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $111,980,627 | 4,419,125 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $102,211,679 | 3,852,683 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $116,627,563 | 4,029,978 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $108,461,811 | 3,876,405 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $103,721,702 | 3,737,719 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $82,600,669 | 2,869,075 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $81,942,206 | 2,470,371 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $93,124,907 | 2,538,847 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $93,766,804 | 2,298,206 | Shares | Sole | 2023-05-25 | |
| No filing history on record for this holder in this stock. | ||||||